Skip to content
Screener

Insmed INSM Income Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$425.49M+296%$305.96M+230%$263.84M+153%$142.34M+52.4%$107.42M+18.9%
$67.21M+139%$47.42M+123%$44.22M+69.1%$29.37M+38.7%$28.08M+33.9%
$210.03M+18.5%$209.49M+37.3%$254.91M+41.8%$186.42M+23.6%$177.19M+20.7%
$247.47M+59.9%$247.26M+67.6%$212.48M+49.1%$186.38M+56.7%$154.76M+45.2%
$427.03M+1.6%$459.28M+34.7%$583.59M+74.3%$508.35M+65.7%$420.29M+10.8%
-$1.55M+99.5%-$153.32M+38.2%-$319.75M-38.8%-$366.01M-71.5%-$312.88M-8.3%
-0.4%+291pp-50.1%+217pp-121.2%+99.4pp-257.1%-28.7pp-291.3%+28.5pp
$20.27M-4.6%$20.08M-6.9%$20.6M-4.4%$20.38M-3.2%$21.25M-0.1%
-$531K-217%-$736K-658%-$1.82M—-$603K-133%$453K+268%
-$11.37M+96.5%-$162.1M+36.6%-$326.93M-39.5%-$368.7M-68.0%-$320.44M-6.9%
$1.87M+50.4%$1.47M+60.6%$1.55M+22.5%$1.32M+30.2%$1.24M+48.3%
-$13.24M+95.9%-$163.56M+36.3%-$328.49M-39.5%-$370.02M-67.8%-$321.69M-7.0%
-3.1%+296pp-53.5%+223pp-124.5%+101pp-260%-23.9pp-299.5%+33.3pp
-$0.06+96.5%-$0.76+46.5%-$1.53-17.7%-$1.75-37.8%-$1.70+12.4%
$3.71M+101%-$148.31M+39.5%-$314.19M-38.0%-$362.01M-71.8%-$309.13M-8.0%
0.9%+289pp-48.5%+215pp-119.1%+98.9pp-254.3%-28.8pp-287.8%+29.0pp
-$1.55M+99.5%-$153.32M+38.2%-$319.75M-38.8%-$366.01M-71.5%-$312.88M-8.3%

FAQ

What is Insmed's revenue?
Insmed (INSM) generated $1.1B in revenue over the trailing twelve months, up 185.8% year over year.
Is Insmed profitable?
Insmed is not currently profitable: it reported a net loss of $875.3M over the trailing twelve months, a -76.9% net margin.
What are Insmed's profit margins?
Gross margin is 83.5% and operating margin is -73.9%, with a -76.9% net margin.
What is Insmed's earnings per share?
Insmed's diluted EPS over the trailing twelve months is $-4.10.
Where does Insmed's income statement data come from?
Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.